Intech Investment Management LLC Buys 24,125 Shares of HealthEquity, Inc. $HQY

Key Points

• Intech Investment Management LLC increased its stake in HealthEquity, Inc. by 73.9% during the first quarter, acquiring an additional 24,125 shares to hold a total of 56,775 shares valued at approximately $5.02 million.
• HealthEquity's stock received several analyst upgrades, with Deutsche Bank raising its price target from $98 to $115 and Bank of America lifting it from $110 to $125, indicating a strong positive outlook.
• The stock currently has a market capitalization of $7.97 billion, with a twelve-month price range between $74.07 and $116.65, reflecting significant investor interest and activity.

Intech Investment Management LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 73.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 56,775 shares of the company's stock after buying an additional 24,125 shares during the period. Intech Investment Management LLC owned about 0.07% of HealthEquity worth $5,017,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of HQY. Ieq Capital LLC grew its position in HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock valued at $260,000 after acquiring an additional 123 shares during the period. Xponance Inc. boosted its stake in shares of HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after purchasing an additional 136 shares in the last quarter. Fifth Third Bancorp grew its holdings in shares of HealthEquity by 17.5% in the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock worth $84,000 after purchasing an additional 142 shares during the last quarter. AlphaQ Advisors LLC increased its position in shares of HealthEquity by 5.1% during the 1st quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company's stock worth $303,000 after purchasing an additional 165 shares in the last quarter. Finally, State of Wyoming lifted its holdings in HealthEquity by 2.9% during the 1st quarter. State of Wyoming now owns 5,915 shares of the company's stock valued at $523,000 after purchasing an additional 169 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Trading Up 0.2%

HQY stock opened at $92.49 on Friday. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The company has a market cap of $7.97 billion, a P/E ratio of 56.05, a PEG ratio of 1.32 and a beta of 0.50. The business has a fifty day moving average of $93.46 and a 200-day moving average of $94.50.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. Royal Bank Of Canada raised their price target on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a report on Wednesday, September 3rd. JMP Securities boosted their price objective on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Barrington Research restated an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. Finally, Bank of America lifted their price target on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $119.77.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.